Product Information
XROMI 100 MG/ML SOLUTION is a brand product labeled by Nova Laboratories, Ltd., priced at $4.9667 per ML under NDC 62484001505. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Apr 4, 2024.
The High Outlier badge above means this manufacturer's average price in the Hydroxyurea market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/mL
Manufacturer
Nova Laboratories, Ltd.NDC
62484001505
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYUREAApproval Type
New Drug (NDA)
FDA Application
NDA216593FDA Approved
4/4/2024
On Market Since
4/4/2024
Pharmacological Classes
Price Statistics
The NADAC for XROMI 100 MG/ML SOLUTION has been published 50 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9667 per ML |
|---|---|
| All-time high | $4.9667 (Sep 30, 2026) |
| All-time low | $4.9014 (Oct 22, 2025) |
| 52-week high | $4.9667 |
| 52-week low | $4.9014 |
| Median price | $4.9519 |
| Average price | $4.9462 |
| Largest weekly change | +0.5% (Nov 19, 2025) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydroxyurea market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nova Laboratories, Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydroxyurea market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XROMI 100 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for XROMI 100 MG/ML SOLUTION, manufactured by Nova Laboratories, Ltd., is $4.9667 per ML (NDC 62484001505), effective Sep 30, 2026.
How has the price of XROMI 100 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for XROMI 100 MG/ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for XROMI 100 MG/ML SOLUTION?
Since Oct 22, 2025, the NADAC for XROMI 100 MG/ML SOLUTION has ranged from a low of $4.9014 (Oct 22, 2025) to a high of $4.9667 (Sep 30, 2026), with a median of $4.9519 per ML.
Are there cheaper alternatives to XROMI 100 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of XROMI 100 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XROMI 100 MG/ML SOLUTION?
XROMI 100 MG/ML SOLUTION (NDC 62484001505) is labeled by Nova Laboratories, Ltd., and CMS classifies it as a brand product.